Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1631726
Max Phase: Preclinical
Molecular Formula: C15H16N4S
Molecular Weight: 284.39
Molecule Type: Small molecule
Associated Items:
ID: ALA1631726
Max Phase: Preclinical
Molecular Formula: C15H16N4S
Molecular Weight: 284.39
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C/C(=N\NC(=S)Nc1ccc(C)cc1)c1ccccn1
Standard InChI: InChI=1S/C15H16N4S/c1-11-6-8-13(9-7-11)17-15(20)19-18-12(2)14-5-3-4-10-16-14/h3-10H,1-2H3,(H2,17,19,20)/b18-12+
Standard InChI Key: ZKSCCNZKLCCYNG-LDADJPATSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 284.39 | Molecular Weight (Monoisotopic): 284.1096 | AlogP: 3.10 | #Rotatable Bonds: 3 |
Polar Surface Area: 49.31 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.30 | CX Basic pKa: 2.88 | CX LogP: 3.43 | CX LogD: 3.43 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.52 | Np Likeness Score: -2.17 |
1. Lessa JA, Mendes IC, da Silva PR, Soares MA, dos Santos RG, Speziali NL, Romeiro NC, Barreiro EJ, Beraldo H.. (2010) 2-Acetylpyridine thiosemicarbazones: cytotoxic activity in nanomolar doses against malignant gliomas., 45 (12): [PMID:20884094] [10.1016/j.ejmech.2010.09.021] |
2. PubChem BioAssay data set, |
3. Klayman DL, Bartosevich JF, Griffin TS, Mason CJ, Scovill JP.. (1979) 2-Acetylpyridine thiosemicarbazones. 1. A new class of potential antimalarial agents., 22 (7): [PMID:376848] [10.1021/jm00193a020] |
4. Pape VF,Tóth S,Füredi A,Szebényi K,Lovrics A,Szabó P,Wiese M,Szakács G. (2016) Design, synthesis and biological evaluation of thiosemicarbazones, hydrazinobenzothiazoles and arylhydrazones as anticancer agents with a potential to overcome multidrug resistance., 117 [PMID:27161177] [10.1016/j.ejmech.2016.03.078] |
Source(2):